Trials / Not Yet Recruiting
Not Yet RecruitingNCT07470983
A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With Primary Aldosteronism
A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of HRS-1780 in Participants With Primary Aldosteronism
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Shandong Suncadia Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a multicenter, randomized, double-blind, placebo-parallel-controlled phase II clinical trial to evaluate the efficacy and safety of HRS-1780 compared with placebo in participants with primary aldosteronism. The study plans to enroll 60 participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-1780 Tablets | HRS-1780 Tablets |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2026-04-01
- Primary completion
- 2026-11-01
- Completion
- 2026-11-01
- First posted
- 2026-03-13
- Last updated
- 2026-04-07
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT07470983. Inclusion in this directory is not an endorsement.